It is the butterfly effect in action. Weak growth outlooks in the Gulf states are prompting greater competition from local clinics, stemming the flow of visitors to the world’s top medical tourism destination.
That is clouding the outlook for Thailand’s healthcare shares, which surged more than 800 percent over the past seven years, as valuations start to look stretched amid falling demand. Bangkok’s Bumrungrad Hospital PLC, known as the grandaddy of international clinics, has slumped 16 percent since early March after patient volumes from the United Arab Emirates (UAE), its second-biggest source of overseas visitors, fell 20 percent in the first quarter.
Thailand attracted as many as 1.8 million international patients last year, many staying on afterward for a beach holiday. More than one in three foreigners treated at Bumrungrad are from the Gulf states, and Kasikorn Securities Co says declining growth in the region and a rise in competition from clinics in the UAE, where the government is encouraging its citizens to undergo medical care at home, are curbing demand.
“In the short term, the economic slowdown in the the Middle East will weaken some investors’ confidence on earnings growth for domestic hospital operators,” said Jintana Mekintharanggur, the Bangkok-based director of equity investment at Manulife Asset Management.
“We are still bullish on the sector” in the long term, as it will benefit from growth in nations such as Myanmar and Vietnam that have less-developed health systems, she said.
The SET Health Care Services Index has fallen 2.7 percent since closing at a record high on April 21. It is still the best-performing industry group in the SET Index, rallying almost 28 percent over the past 12 months. It trades at 6.8 times its book value, compared with 3.8 for the MSCI World Health Care Index.
The health gauge fell 0.3 percent as of 10:31am in Bangkok yesterday, the worst performer among 28 industry groups on the SET Index, which was up 0.7 percent. Bangkok Dusit Medical Services PLC, which has the biggest weighting on the measure, dropped 0.8 percent.
“Most hospital stocks have very stretched valuations, which has probably spurred some concern about overestimated earnings potential,” said Adithep Vanabriksha, Bangkok-based chief investment officer at Aberdeen Asset Management PLC. “We still see their growth potential, but have to be very careful with the current share prices.”
Between 1.3 million and 1.8 million medical tourists traveled to Thailand last year, according to figures from Patients Beyond Borders, a consulting firm in Chapel Hill, North Carolina. The nation is well known for cosmetic and sex change procedures. Medical tourism generated 107 billion baht (US$3 billion) of revenue in 2014, according to the latest Thai government estimate.
Sitting at the apex of the industry is Bumrungrad, which attracts more than half a million foreign patients a year and has a network of 32 referral offices everywhere from Mongolia to Ethiopia. Sixty-seven percent of revenue came from overseas visitors last quarter, company figures showed. Burmese were the biggest source, accounting for 8.4 percent of total patients, followed by 8.3 percent from the UAE and 5.9 percent from Oman.
Kasikorn Securities downgraded its earning forecasts for Bumrungrad by 8 percent to 13 percent in 2016 to 2018 to reflect the weak economic outlook in the Gulf and rising competition from Abu Dhabi’s al-Noor Hospitals Group, according to a May 19 note by analyst Jitima Ratanatam in Bangkok.
The UAE’s economy has been hit by the plunge in oil prices since the middle of 2014 and is forecast to expand 2.5 percent this year, from more than 7 percent in 2012.
Other Thai hospitals are also under pressure. Chiang Mai Ram Medical Business PLC reported a 41 percent slump in first-quarter profit. Bangkok Dusit was downgraded to “neutral” from “outperform” by Credit Suisse Group AG last week.
Recognizing the importance of healthcare to the economy, Thai Prime Minister Prayuth Chan-ocha’s military government has drafted a 10-year plan to promote the sector. As part of the plan, the staying period for medical treatment for patients from China, Laos, Cambodia, Myanmar and Vietnam has been tripled to 90 days.
Even if Middle East demand keeps declining, growth in Southeast Asia is likely to support the industry, said Voravan Tarapoom, Bangkok-based chief executive officer at BBL Asset Management Co.
Manulife has cut holdings in Bangkok Dusit because its rising share price provided an opportunity to lock in profit, Jintana said.
It is buying Bumrungrad because it has dropped to an attractive level and Manulife is also looking at other health companies, but is wary of high valuations, she said.
“Healthcare stocks were the good defensive stocks during the market downturn,” said Kasem Prunratanamala, the head of research at CIMB Securities Co in Bangkok. “Now, with the high valuations, those shares have lost a little bit of allure.”
The Investment Commission yesterday approved a Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) application to invest an additional US$3.5 billion in its Arizona subsidiary to manufactured advanced chips. The world’s largest contract chipmaker’s board of directors last month approved the funding project after TSMC started moving manufacturing equipment into the fab in December last year in preparation for the production of 4-nanometer chips next year. TSMC said it has also commenced the second phase of facility construction in Arizona. The second fab is to produce semiconductors using 3-nanometer technology in 2026. Altogether, TSMC plans to spend US$40 billion on the Arizona fabs, doubling its
KEY SECTOR: Taiwan’s new chip legislation is insufficient, and a more strategic ‘chip act’ that covers the whole semiconductor ecosystem is needed, MediaTek’s chairman said MediaTek Inc (聯發科) chairman Rick Tsai (蔡明介) yesterday urged the government to formulate a state semiconductor strategy and comprehensive “chip act” that includes local chip designers and smaller-scale semiconductor companies, as they are facing intensifying competition from China. The government is playing an increasingly important role in safeguarding the local semiconductor industry’s competitiveness, given that the US, the EU and Japan are offering hefty subsidies and significant tax incentives to build semiconductor capacity domestically, as they have realized the strategic importance of semiconductors, Tsai said. To implement such a program, the government should take steps to finance a “chip act,” Tsai said
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
MOUNTING PRESSURE: Although bank failures in the US and Europe would not cause systemic risks, it would dampen consumers’ willingness to spend, GlobalWafers said GlobalWafers Co (環球晶圓), the world’s third-largest silicon wafer supplier, yesterday said that the financial turmoil in the US and Europe has dimmed the outlook for chip demand in the second half of this year, as growing economic uncertainty could dampen consumer spending. The Hsinchu-based wafer manufacturer said it is seeing greater pressure from economic uncertainty on the industry’s recovery, as customers would have not expected Silicon Valley Bank, Signature Bank and a tier-one bank like Credit Suisse Group SA to collapse suddenly. Although the failures are unlikely to cause systemic risks, consumers would be cautious of spending on non-essential items, such
RSS